Antigens, Tumor-Associated, Carbohydrate
"Antigens, Tumor-Associated, Carbohydrate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies.
Descriptor ID |
D015295
|
MeSH Number(s) |
D23.050.285.050 D23.050.550.325 D23.101.140.075
|
Concept/Terms |
Antigens, Tumor-Associated, Carbohydrate- Antigens, Tumor-Associated, Carbohydrate
- Carbohydrate Antigens, Tumor-Associated
- Antigens, Tumor-Associated Carbohydrate
- Carbohydrate Antigens, Tumor Associated
- Tumor-Associated Carbohydrate Antigens
- Tumor Associated Carbohydrate Antigens
- CA Antigen
- Antigen, CA
- Epitectin
- CA(Oxford) Antigen
- Cancer-Associated Carbohydrate Antigens
- Antigens, Cancer-Associated Carbohydrate
- Cancer Associated Carbohydrate Antigens
- Carbohydrate Antigens, Cancer-Associated
- Antigen, Carcinoma-Associated
- Antigen, Carcinoma Associated
- Carcinoma-Associated Antigen
- Carcinoma Associated Antigen
- Antigens, Carbohydrate, Tumor-Associated
- CA Antigens
- Antigens, CA
|
Below are MeSH descriptors whose meaning is more general than "Antigens, Tumor-Associated, Carbohydrate".
Below are MeSH descriptors whose meaning is more specific than "Antigens, Tumor-Associated, Carbohydrate".
This graph shows the total number of publications written about "Antigens, Tumor-Associated, Carbohydrate" by people in this website by year, and whether "Antigens, Tumor-Associated, Carbohydrate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 1 | 2 |
1999 | 1 | 0 | 1 |
2007 | 0 | 2 | 2 |
2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antigens, Tumor-Associated, Carbohydrate" by people in Profiles.
-
Reese Z, Straubhar A, Pal SK, Agarwal N. Ipilimumab in the treatment of prostate cancer. Future Oncol. 2015; 11(1):27-37.
-
Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007 Nov 20; 25(33):5287-312.
-
Cristofanilli M, Broglio KR, Guarneri V, Jackson S, Fritsche HA, Islam R, Dawood S, Reuben JM, Kau SW, Lara JM, Krishnamurthy S, Ueno NT, Hortobagyi GN, Valero V. Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer. 2007 Feb; 7(6):471-9.
-
Zimmerman RL, Fogt F, Bibbo M. Diagnostic utility of sialosyl-Tn in discriminating carcinomatous cells from benign mesothelium in body cavity effusions. Acta Cytol. 1999 Nov-Dec; 43(6):1079-84.
-
Werther JL, Tatematsu M, Klein R, Kurihara M, Kumagai K, Llorens P, Guidugli Neto J, Bodian C, Pertsemlidis D, Yamachika T, Kitou T, Itzkowitz S. Sialosyl-Tn antigen as a marker of gastric cancer progression: an international study. Int J Cancer. 1996 Jun 21; 69(3):193-9.
-
Hayes DF. Serum (circulating) tumor markers for breast cancer. Recent Results Cancer Res. 1996; 140:101-13.
-
Krupnick JG, Damjanov I, Damjanov A, Zhu ZM, Fenderson BA. Globo-series carbohydrate antigens are expressed in different forms on human and murine teratocarcinoma-derived cells. Int J Cancer. 1994 Dec 1; 59(5):692-8.
-
Damjanov I, Zhu ZM, Andrews PW, Fenderson BA. Embryonal carcinoma cells differentiate into parietal endoderm via an intermediate stage corresponding to primitive endoderm. In Vivo. 1994 Nov-Dec; 8(6):967-73.
-
Kuhn JA, Thomas G. Monoclonal antibodies and colorectal carcinoma: a clinical review of diagnostic applications. Cancer Invest. 1994; 12(3):314-23.
-
Fenderson BA, Andrews PW. Carbohydrate antigens of embryonal carcinoma cells: changes upon differentiation. APMIS Suppl. 1992; 27:109-18.